Pioneers in Medical Robotics
AVRA’s ( OTC: AVMR ) medical team were among the earliest adopters to perform robotically assisted, minimally-invasive surgery. Surgical robotic systems have yet to realize their potential in terms of improved accuracy, navigation, targeting, imaging and visualization, allowing for penetration into all aspects of surgical care. AVRA’s Surgeons are partnering with engineers and scientists to design and develop a novel, computer-integrated, semi/autonomous robotic platform that is truly disruptive.
Market Opportunity: Aesthetic Medicine
AVRA is currently developing a unique surgical robotic platform in the field of Aesthetics. The proprietary intelligent AVRA Instrument Guidance System (AIGS) will enable surgeons to simulate procedures for preoperative review prior to performing surgery. Patient specific mapping optimizes results both for the surgeon and the patient.
According to the American Society for Aesthetic Plastic Surgery (ASAPS), the field of aesthetics is a $13.5 billion industry, with explosive growth in non-surgical treatments.
A View Into Our Labs
In this video, Andrea Adkins, Assistant Director, Office of Technology Transfer at the University of Central Florida will take you through a simulation and demonstration of the Avra Medical Robotics System.
Patient Inspired Technology
AVRA is a surgical digital technology company whose primary goal is to provide surgeons with the ability to achieve consistently excellent results for the patient. Employing advanced technology, AVRA is developing an intelligent robotic platform combining attributes of imaging with target acquisition and guidance to navigate with unprecedented accuracy and precision. These advanced, semi/autonomous systems will have boundless diagnostic and therapeutic applications – Target, Diagnose, Treat.